Literature DB >> 14789264

Experimental studies of asbestosis.

A J VORWALD, T M DURKAN, P C PRATT.   

Abstract

Entities:  

Keywords:  PNEUMOCONIOSIS

Mesh：

Year:  1951        PMID： 14789264

Source DB:  PubMed          Journal:  AMA Arch Ind Hyg Occup Med        ISSN： 0096-6703


× No keyword cloud information.
  27 in total

1.  CARDIOPULMONARY FUNCTION STUDIES IN WORKERS DEALING WITH ASBESTOS AND GLASSWOOL.

Authors:  J BJURE; B SOEDERHOLM; J WIDIMSKY
Journal:  Thorax       Date:  1964-01       Impact factor: 9.139

2.  Asbestos and cancer: history and public policy.

Authors:  B I Castleman
Journal:  Br J Ind Med       Date:  1991-06

3.  Desquamative interstitial pneumonia associated with chrysotile asbestos fibres.

Authors:  J A Freed; A Miller; R E Gordon; A Fischbein; J Kleinerman; A M Langer
Journal:  Br J Ind Med       Date:  1991-05

4.  Asbestos content of dust encountered in brake maintenance and repair.

Authors:  W J Smither
Journal:  Proc R Soc Med       Date:  1977-05

5.  A commentary on Roggli's "The So-Called Short-Fiber Controversy".

Authors:  David Egilman; Triet Tran
Journal:  Int J Occup Environ Health       Date:  2016-05-24

6.  Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos. Longitudinal light and electron microscopic studies on the rat model.

Authors:  E Fasske
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

7.  The fibrogenic effects of mineral dusts injected into the pleural cavity of mice.

Authors:  J M Davis
Journal:  Br J Exp Pathol       Date:  1972-04

8.  Pulmonary fibrogenic response of guinea pigs to amosite dust.

Authors:  P N Viswanathan; R K Dogra; R Shanker; S H Zaidi
Journal:  Int Arch Arbeitsmed       Date:  1973

9.  Electron microscope characteristics of inhaled chrysotile asbestos fibre.

Authors:  F D Pooley
Journal:  Br J Ind Med       Date:  1972-04

Review 10.  Health risk of chrysotile revisited.

Authors:  David Bernstein; Jacques Dunnigan; Thomas Hesterberg; Robert Brown; Juan Antonio Legaspi Velasco; Raúl Barrera; John Hoskins; Allen Gibbs
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.